SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Spyre Therapeutics Files Form 10-Q

Spyre Therapeutics filed a Form 10-Q for the period ended September 30.

SYRE

Related stories